Answers are grounded in this paper and cite their sources.
The potential role of blood–brain barrier (BBB)-associated tight junction proteins in attention-deficit/hyperactivity disorder (ADHD) has not yet been fully elucidated. This cross-sectional case–control study aimed to evaluate serum claudin-5, claudin-11, claudin-12, and claudin-25 levels in children with ADHD, investigate their associations with symptom severity, and assess their diagnostic performance. The study included 40 children diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria and 40 age-matched healthy controls. Diagnostic assessment was performed using the Turkish adaptation of the Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version for DSM-5 (K-SADS-PL-DSM-5), and ADHD symptom severity was evaluated using the teacher form of the Turgay DSM-IV-Based Child and Adolescent Behavior Disorders Screening and Rating Scale. Serum claudin levels were measured using an enzyme-linked immunosorbent assay (ELISA). Serum claudin-12 and claudin-25 levels were higher in the ADHD group than in controls (both p < 0.001), whereas claudin-5 and claudin-11 levels did not differ significantly between groups. Within the ADHD group, serum claudin levels were not significantly correlated with teacher-reported symptom severity, except for a weak negative correlation between claudin-25 and hyperactivity/impulsivity (rs = −0.330, p = 0.037) that did not withstand correction for multiple comparisons. After adjustment for age, sex, and body mass index (BMI), higher claudin-12 (adjusted odds ratio [OR] = 1.006, 95% confidence interval [CI]: 1.003–1.010; p < 0.001) and claudin-25 levels (adjusted OR = 1.002, 95% CI: 1.001–1.004; p = 0.010) remained associated with ADHD status. Receiver operating characteristic (ROC) analyses yielded areas under the curve (AUCs) of 0.817 for claudin-12 and 0.782 for claudin-25. In this limited study, serum claudin-12 and claudin-25 concentrations were higher in children with ADHD than in healthy controls. However, these findings do not establish blood–brain barrier dysfunction or the clinical diagnostic utility of these proteins. Their tissue origin, biological significance, and diagnostic performance require further investigation and independent validation.
No takes yet. Share an insight, caveat, or question.
ELÇİ et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: